DNA Robots for CRISPR/Cas12a Activity Management and Universal Platforms for Biosensing

Xinyi Xia1, Qiutong Chen1, Tongshan Zuo1

  • 1School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Analytical Chemistry
|January 13, 2024
PubMed
Summary

We developed a novel DNA Robots for Enzyme Activity Management (DREAM) strategy to precisely control CRISPR/Cas12a systems for enhanced biosensing and molecular diagnostics.